Intravenous thrombolysis with recombinant tissue plasminogen activator (r-tPA) was recommended for acute ischemic stroke (AIS) patients within 4.5 h of stroke onset, and an increasing trend of r-tPA treatment was discovered over the past 13 years (2). The gene discussed is PLAT; the disease is androgen insensitivity syndrome.